Article Sidebar
Published:
Apr 19, 2023Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
Identification of immune regulatory protein coding genes in the development of lung adenocarcinom a (LUAD)
Abstract
Purpose: To verify the differential expressed genes (DEGs) based on The Cancer Genome Atlas (TCGA) using RNA-seq data from eight LUAD patients
Methods: TCGA database was used for extraction and analysis of RNA-seq profile in LUAD patients. Then RNA sequencing was performed using the tissue samples from eight LUAD patients for comparison. Weighted correlation network analysis (WGCNA) was applied to establish the co-expression modules and identify hub genes using RNA-seq data from the eight LUAD patients. Protein-protein interaction (PPI) analysis was used to reveal hub genes and GO analysis was performed for functional annotation including immune responses.
Results: ALDH3A1, METTL7B, WFDC2 and CDH23 that had close correlation with the immune system were identified by TCGA and validated by RNA-seq from the eight LUAD patients. IL17REL was revealed as a potential oncogene in LUAD.
Conclusion: This study highlighted potentially useful biomarkers associated with LUAD development and diagnosis.
